Format

Send to

Choose Destination
Trop Med Int Health. 2012 Nov;17(11):1386-90. doi: 10.1111/j.1365-3156.2012.03073.x. Epub 2012 Sep 14.

The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.

Author information

1
School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa  Empilweni Service and Research Unit, Rahima Moosa Mother and Child Hospital and University of Witwatersrand, Johannesburg, South Africa  Red Cross Children's Hospital and School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa  Wits Reproductive Health and HIV Institute (Harriet Shezi Children's Clinic, Chris Hani Baragwanath Hospital, Soweto), Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa  Tygerberg Academic Hospital, University of Stellenbosch, Stellenbosch, South Africa  Médecins Sans Frontières South Africa and Khayelitsha ART Programme, Khayelitsha, Cape Town, South Africa  Sinikithemba Clinic, McCord Hospital, Durban, South Africa  Gugulethu Community Health Centre and Desmond Tutu HIV Centre, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa  Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

Abstract

OBJECTIVES:

To determine the improvement in positive predictive value of immunological failure criteria for identifying virological failure in HIV-infected children on antiretroviral therapy (ART) when a single targeted viral load measurement is performed in children identified as having immunological failure.

METHODS:

Analysis of data from children (<16 years at ART initiation) at South African ART sites at which CD4 count/per cent and HIV-RNA monitoring are performed 6-monthly. Immunological failure was defined according to both WHO 2010 and United States Department of Health and Human Services (DHHS) 2008 criteria. Confirmed virological failure was defined as HIV-RNA >5000 copies/ml on two consecutive occasions <365 days apart in a child on ART for ≥18 months.

RESULTS:

Among 2798 children on ART for ≥18 months [median (IQR) age 50 (21-84) months at ART initiation], the cumulative probability of confirmed virological failure by 42 months on ART was 6.3%. Using targeted viral load after meeting DHHS immunological failure criteria rather than DHHS immunological failure criteria alone increased positive predictive value from 28% to 82%. Targeted viral load improved the positive predictive value of WHO 2010 criteria for identifying confirmed virological failure from 49% to 82%.

CONCLUSION:

The addition of a single viral load measurement in children identified as failing immunologically will prevent most switches to second-line treatment in virologically suppressed children.

KEYWORDS:

HIV; VIH; antiretroviral therapy; antirétroviral; children; enfants; fallo inmunológico; fallo virológico; immunological failure; monitoring; monitorización; niños; suivi; terapia antirretroviral; thérapie; virological failure; échec immunologique; échec virologique VIH

PMID:
22974345
PMCID:
PMC3830726
DOI:
10.1111/j.1365-3156.2012.03073.x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center